Skip to main content
News Tag: news
NRG Oncology Trial Indicates Using Atezolizumab with Chemoradiation is Safe and Demonstrates Signs of Immune Activation in Women with Cervical Cancer
Read More
HRR Mutational Status Prognostic of Survival Outcomes in Biomarker Analysis of NRG Oncology Trial for Women with Recurrent Platinum-Sensitive Ovarian Cancer
Read More
OlympiA Trial (NSABP B-55): Olaparib as adjuvant treatment reduces risk of death by 32% in patients with germline BRCA mutations and high-risk early breast cancer
Read More
NRG Oncology seeks to fill the position of Co-Chair, Patient Centered Outcomes Research Committee
Read More
NRG Oncology PSC 2022 Winter Meeting Wrap Up
Read More
Congratulations to the NRG Oncology Members Assigned to NCI Gastrointestinal Task Forces – Rectal/Anal Cancers
Read More
FORTE Study Update – March NRG Newsletter
Read More
Coming Attractions or Recent Additions in NRG Colorectal Cancer Research: NRG-GI005
Read More
Coming Attractions or Recent Additions in NRG Colorectal Cancer Research: NRG-GI008
Read More
The NRG-GI004/SWOG1610, the COMMIT Study, may further improve outcomes in Metastatic Colorectal Cancer with deficiency of DNA repair (dMMR/MSI- H)
Read More